series-c-plus
Stage
2
Investors
About
Intelliseq develops a cloud-based platform called iFlow for automated analysis and clinical interpretation of genomic next-generation sequencing data, offering modules for hereditary disorders, somatic mutations, pharmacogenomics, and polygenic risk scores.
Explore Intelliseq's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.